News

Study Says Senate Reform Plan Will Raise Premiums


 

WASHINGTON — A report commissioned by the Blue Cross Blue Shield Association says that individuals buying insurance on the open market will pay 54% more in premiums than they do today if the Senate health reform bill is enacted.

The analysis had been in the works for awhile, but comes on the heels of a Congressional Budget Office that estimated premium costs for individuals and the group market if all the Senate reform proposals were adopted and put into place by the scheduled 2016 implementation date. The CBO report estimated that individuals would pay $5,800 a year for premiums, a slight increase from the $5,500 they could expect to pay under current law.

The individual premium, without federal subsidies, would also be about 10%-13% higher than premiums paid by group members under the reform proposal, said the CBO. But the agency estimated that slightly more than half of those individuals would be eligible for federal subsidies. Those individuals would actually pay 56%-59% less than someone in a group would pay, the CBO estimated.

The BlueCross analysis, which was conducted by the actuarial company Oliver Wyman Inc., estimated that individuals would pay $4,561 in annual premiums, or 54% more than they would pay without reform. Small group premiums (for employers with 2-50 workers) will be about 20% higher, according to the analysis. Both figures exclude medical inflation, so the increases could be even greater, said Jason Grau, an associate partner at Oliver Wyman and a co-author of the analysis.

The Wyman analysis calculated premiums for the year 2019, a few years after the market had settled into the new law, he said.

The CBO underestimated the effects of adverse selection, which he said was more likely given that the Senate bill had minimal penalties for those who choose not to purchase insurance. The lack of stiff fines and the elimination of age rating—in which younger, healthier people pay less—means that insurers will have to raise premiums to cover costs for the older, sicker population likely to sign up for policies, said Mr. Grau.

Recommended Reading

U.S. Issues Rules for Use of Genetic Information
MDedge Family Medicine
Conflicts of Interest Are Not Always Disclosed
MDedge Family Medicine
Massachusetts Survey: ED Visits Still a Problem
MDedge Family Medicine
Cost Concerns Need Not Limit Drug Options
MDedge Family Medicine
Policy & Practice
MDedge Family Medicine
Two Boards Join to Offer Hospitalist Certification
MDedge Family Medicine
Multispecialty Groups Feel Recession's Pinch
MDedge Family Medicine
Survey: Medicare Preferred to Private Insurers
MDedge Family Medicine
When to Buy an EHR: AAFP Experts Weigh In
MDedge Family Medicine
An Ironman Competes to Give Back
MDedge Family Medicine